365 related articles for article (PubMed ID: 10948322)
1. Comparative assessment of MHC antigen expression in bladder and testis tumour biopsies and established urological tumour cell lines: the relevance of cytokine and gene transfection for correction of defective MHC antigens.
Nouri AM; Symes MO
Oncol Rep; 2000; 7(5):959-64. PubMed ID: 10948322
[TBL] [Abstract][Full Text] [Related]
2. Accurate and rapid assessment of MHC antigen upregulation following cytokine stimulation.
Gillott DJ; Nouri AM; Compton SJ; Oliver RT
J Immunol Methods; 1993 Oct; 165(2):231-9. PubMed ID: 8228273
[TBL] [Abstract][Full Text] [Related]
3. The frequency of major histocompatibility complex antigen abnormalities in urological tumours and their correction by gene transfection or cytokine stimulation.
Nouri AM; Hussain RF; Oliver RT
Cancer Gene Ther; 1994 Jun; 1(2):119-23. PubMed ID: 7621243
[TBL] [Abstract][Full Text] [Related]
4. Defective expression of adhesion molecules on human bladder tumour and human tumour cell lines.
Nouri AM; Hussain RF; Dos Santos AV; Oliver RT
Urol Int; 1996; 56(1):6-12. PubMed ID: 8903546
[TBL] [Abstract][Full Text] [Related]
5. Induction of MHC antigens by tumour cell lines in response to interferons.
Nouri AM; Hussain RF; Dos Santos AV; Gillott DJ; Oliver RT
Eur J Cancer; 1992; 28A(6-7):1110-5. PubMed ID: 1378291
[TBL] [Abstract][Full Text] [Related]
6. Intensity of class I antigen expression on human tumour cell lines and its relevance to the efficiency of non-MHC-restricted killing.
Nouri AM; Hussain RF; Dos Santos AV; Mansouri M; Oliver RT
Br J Cancer; 1993 Jun; 67(6):1223-8. PubMed ID: 8512807
[TBL] [Abstract][Full Text] [Related]
7. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
[TBL] [Abstract][Full Text] [Related]
8. Combination of HPLC and solid-phase binding assay for isolation and purification of MHC class I and associated peptides using a bladder tumour cell line.
Torabi-Pour N; Nouri AM; Perrett D; Oliver RT
Biomed Chromatogr; 2001 Feb; 15(1):18-24. PubMed ID: 11180296
[TBL] [Abstract][Full Text] [Related]
9. Modulation by canine interferon-gamma of major histocompatibility complex and tumor-associated antigen expression in canine mammary tumor and melanoma cell lines.
Whitley EM; Bird AC; Zucker KE; Wolfe LG
Anticancer Res; 1995; 15(3):923-9. PubMed ID: 7645983
[TBL] [Abstract][Full Text] [Related]
10. Immunological paradox in testicular tumours: the presence of a large number of activated T-cells despite the complete absence of MHC antigens.
Nouri AM; Hussain RF; Oliver RT; Handy AM; Bartkova I; Bodmer JG
Eur J Cancer; 1993; 29A(13):1895-9. PubMed ID: 8260249
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of melanoma-associated antigens and molecules involved in antigen processing and presentation in three cell lines established from a single patient.
Kovalcsik E; John J; Turner M; Birchall L; Sage D; Whittle R; Dalgleish A; Pandha H
Melanoma Res; 2004 Dec; 14(6):463-71. PubMed ID: 15577316
[TBL] [Abstract][Full Text] [Related]
12. MHC class I and II expression in prostate carcinoma and modulation by interferon-alpha and -gamma.
Bander NH; Yao D; Liu H; Chen YT; Steiner M; Zuccaro W; Moy P
Prostate; 1997 Dec; 33(4):233-9. PubMed ID: 9397194
[TBL] [Abstract][Full Text] [Related]
13. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation.
Meissner M; Whiteside TL; van Kuik-Romein P; Valesky EM; van den Elsen PJ; Kaufmann R; Seliger B
Br J Dermatol; 2008 May; 158(5):930-40. PubMed ID: 18284388
[TBL] [Abstract][Full Text] [Related]
14. Correlation between expression of major histocompatibility complex class I and that of antigen presenting machineries in carcinoma cell lines of the pancreas, biliary tract and colon.
Imanishi T; Kamigaki T; Nakamura T; Hayashi S; Yasuda T; Kawasaki K; Takase S; Ajiki T; Kuroda Y
Kobe J Med Sci; 2006; 52(3-4):85-95. PubMed ID: 16855371
[TBL] [Abstract][Full Text] [Related]
15. Major histocompatibility complex class I and class II expression in renal cell carcinoma and modulation by interferon gamma.
Gastl G; Ebert T; Finstad CL; Sheinfeld J; Gomahr A; Aulitzky W; Bander NH
J Urol; 1996 Jan; 155(1):361-7. PubMed ID: 7490887
[TBL] [Abstract][Full Text] [Related]
16. MHC antigen induction by interferon gamma on cultured mouse pancreatic beta cells and macrophages. Genetic analysis of strain differences and discovery of an "occult" class I-like antigen in NOD/Lt mice.
Leiter EH; Christianson GJ; Serreze DV; Ting AT; Worthen SM
J Exp Med; 1989 Oct; 170(4):1243-62. PubMed ID: 2507727
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of DF3, in association with ICAM-1 and MHC class II by IFN-gamma in short-term human mammary carcinoma cell cultures.
Sgagias MK; Nieroda C; Yannelli JR; Cowan KH; Danforth DN
Cancer Biother Radiopharm; 1996 Jun; 11(3):177-85. PubMed ID: 10851535
[TBL] [Abstract][Full Text] [Related]
18. Induction of specific anti-tumour immunity by interferon-gamma gene-transferred murine bladder carcinoma MBT-2.
Hiura M; Hashimura T; Watanabe Y; Kuribayashi K; Yoshida O
Folia Biol (Praha); 1994; 40(1-2):49-61. PubMed ID: 7958064
[TBL] [Abstract][Full Text] [Related]
19. Isolation of human leukocyte antigen (HLA)-associated peptide(s) in the absence of HLA-restricted specific cytolytic T lymphocytes.
Torabi-Pour N; Nouri AM; Saffie R; Morrow WJ; Oliver RT
Urol Int; 2002; 69(3):219-26. PubMed ID: 12372891
[TBL] [Abstract][Full Text] [Related]
20. Regulation of major histocompatibility (MHC) class II human leukocyte antigen-DR alpha gene expression in thyrocytes by single strand binding protein-1, a transcription factor that also regulates thyrotropin receptor and MHC class I gene expression.
Balducci-Silano PL; Suzuki K; Ohta M; Saito J; Ohmori M; Montani V; Napolitano G; Shong M; Taniguchi SI; Pietrarelli M; Lavaroni S; Mori A; Singer DS; Kohn LD
Endocrinology; 1998 May; 139(5):2300-13. PubMed ID: 9564838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
